European tech companies raised €27.8 billion across 732 deals in Q3 2026, a 32.4% increase from Q3 2025, according to Tech.eu. Buried inside that total is a short list that tells you where investors place their earliest and boldest bets: the ten largest seed rounds of the quarter, topped among the confirmed names by Callosum’s $100 million for an AI infrastructure platform.
This analysis covers what Tech.eu confirmed about the biggest seed rounds in Europe for Q3 2026, what it left unconfirmed, and why the pattern matters to developers and tool builders. Seed checks of this size are a long way from the small raises that used to define the stage. For contrast, look at the $6M seed behind Strawberry Browser, which now reads like a modest opening bid next to Callosum’s round.
One caveat shapes everything below. The Tech.eu extract available for this report names six of the ten rounds. The other four companies, their amounts and their investors are not confirmed, so this article does not guess at them. Where the facts run out, the text says so plainly.
Don't miss new tech stories on Google
Add Tech Insider once in the Google app and our stories appear in your news suggestions.
Europe’s Q3 2026 Funding Total: €27.8 Billion Across 732 Deals
Start with the headline numbers. Tech.eu counted €27.8 billion flowing into European tech companies over 732 deals in the third quarter. That is a 32.4% rise against Q3 2025, a gap large enough to change how founders talk to investors about valuation and timing.
A little arithmetic helps frame the scale. Dividing €27.8 billion by 732 deals gives an average of roughly €38 million per deal, though that figure blends seed rounds, growth rounds and giant late-stage checks, so it describes no single company. Working backward from the 32.4% increase, the implied Q3 2025 total sits near €21.0 billion, which means the market added about €6.8 billion year over year. Those two derived numbers are this article’s own calculations from Tech.eu’s figures, not separate Tech.eu claims.
The takeaway: capital did not merely hold steady in Q3. It grew by about a third, and the seed stage carried some of the loudest evidence. A seed round of $100 million or $55 million would have looked like an outlier at the stage not long ago. In Q3 2026, such rounds made a top-ten list.
The Six Confirmed Seed Rounds at a Glance
Tech.eu identified ten large seed rounds. The confirmed six are below, with the stated use of funds for each. Amounts appear in the currency Tech.eu reported, since converting them would require exchange rates that the source does not supply.
| Company | Seed amount | Sector (per use of funds) | Stated purpose |
|---|---|---|---|
| Callosum | $100 million | AI infrastructure | Develop and scale its AI infrastructure platform |
| microagi | $55 million | Industrial robotics AI | Scale Atlas, build AI infrastructure for industrial robots, expand globally |
| Aptadir Therapeutics | $45 million | Therapeutics | Advance its pipeline of therapeutic candidates |
| ZuriQ | $25.5 million | Quantum computing | Grow the team, accelerate R&D, scale chip fabrication, add qubits |
| INLEAP Photonics | €20 million | Photonics and lasers | Expand production and testing, develop laser technology, grow European operations |
| iPremom | €15 million | Healthcare technology | Clinical validation and commercial rollout of MaiRa |
Add the four dollar-denominated rounds and you reach $225.5 million. Add the two euro-denominated rounds and you reach €35 million. Because the two currencies sit side by side without a conversion in the source, treat those as separate subtotals rather than one blended sum.
Callosum’s $100 Million Seed and the AI Infrastructure Bet
Callosum raised $100 million in seed funding, the largest of the six confirmed rounds. Tech.eu says the money will go toward developing and scaling its AI infrastructure platform. That is the full extent of what the available extract confirms. It gives no product specification, no pricing, no customer list and no investor names.
Even with that thin detail, the size of the check carries information. A nine-figure seed implies investors expect a platform company, not a feature. Infrastructure plays need heavy upfront spending on compute, engineering talent and reliability work before the first meaningful revenue arrives. A $100 million first round buys runway for exactly that kind of slow build.
The same logic has driven the broader AI buildout this year. Our look at the AI infrastructure race and its nine models in five weeks argues that infrastructure spending tends to arrive in waves, with early money flowing to whoever promises to cut cost or latency for everyone else. Callosum’s round fits that pattern, though its actual technical approach remains unconfirmed.
microagi’s $55 Million for Atlas and Industrial Robots
microagi took in $55 million to scale Atlas, build AI infrastructure for industrial robots and expand its operations globally. The word “infrastructure” appears again here, but the target customer differs. Callosum’s description points at AI workloads in general. microagi’s points at the factory floor.
Tech.eu does not detail what Atlas does at a technical level in the extract, so this article will not describe its architecture or performance. What the stated use of funds does show is a company planning to grow outside its home market, since global expansion sits in the plan alongside product scaling.
Robotics seeds are drawing attention across the market. Compare microagi’s round with the $30M pre-seed raised by Enact Intelligence, and the pattern becomes clear: early robotics companies now raise sums that once belonged to Series A. Data pipelines matter here too, as shown by Nvidia’s Flora tool, which labels robot video at $0.72 an hour.
Aptadir Therapeutics: $45 Million to Advance a Pipeline
Aptadir Therapeutics raised $45 million in seed funding to advance its pipeline of therapeutic candidates. The extract does not name the candidates, the disease areas or the development stage, and this article will not supply them.
The inclusion of a therapeutics company in a tech-focused ranking is worth a pause. Tech.eu counts it among European tech companies, which reflects how blurred the boundary between software, data science and drug development has become. A pipeline of candidates costs real money to carry forward, so a $45 million seed buys time for early-stage work rather than a product launch.
ZuriQ and INLEAP Photonics: Hardware With Long Lead Times
ZuriQ: $25.5 Million for Quantum Chips
ZuriQ closed $25.5 million in seed funding. Per Tech.eu, the company will expand its team, accelerate R&D, scale chip fabrication and increase the number of qubits its processor architecture supports. Those four goals describe a hardware company at the very start of its manufacturing curve. Fabrication scale and qubit count are the two numbers that decide whether a quantum processor moves from lab demonstration to usable machine.
INLEAP Photonics: €20 Million for Laser Production
INLEAP Photonics raised €20 million to expand production and testing, develop laser technology, strengthen sales and customer support, and grow its European operations. The mention of sales and customer support suggests a company already shipping or close to shipping product. Production and testing capacity is the bottleneck for many photonics firms, so that line of the funding plan reads as the most concrete in the group.
Both companies sit in physical-layer technology that sits underneath much of the AI and compute story. Neither round is as large as Callosum’s, yet each targets a part of the stack that software teams rarely see and always depend on.
iPremom’s €15 Million and the MaiRa Regulatory Path
iPremom raised €15 million to support clinical validation and the commercial rollout of MaiRa. Tech.eu adds one important condition: the rollout depends on further regulatory approvals in Europe and the US. In plain terms, the money funds the work, but approvals decide the timeline.
That detail separates iPremom from the infrastructure plays above. A software platform can ship an update next week. A clinical product moves on regulators’ calendars. Readers tracking this round should watch for approval announcements rather than revenue numbers, and should treat any claim about MaiRa’s performance as unconfirmed until the company or a regulator publishes it.
What Remains Unconfirmed About the Other Four Rounds
Tech.eu’s list holds ten rounds, and the extract available for this report shows six. The remaining four companies, their amounts, their closing dates, their lead investors, their founders and any on-record quotes are all unconfirmed here. No named speaker’s statement appears in the extract either.
That gap limits what any honest analysis can claim. It would be easy to fill the blanks with plausible sectors or round sizes, and that would be fabrication. Readers who need the full ranking should consult the original Tech.eu piece directly. This article will update only when confirmed details become available.
| Detail | Status in available extract |
|---|---|
| Q3 2026 total (€27.8B, 732 deals) | Confirmed by Tech.eu |
| Year-over-year growth (32.4%) | Confirmed by Tech.eu |
| Six named seed rounds and amounts | Confirmed by Tech.eu |
| Stated use of funds for six companies | Confirmed by Tech.eu |
| Remaining four companies and amounts | Unconfirmed |
| Investors, founders, round dates | Unconfirmed |
| On-record quotes from named speakers | Unconfirmed |
Why This Matters for Coding Tools and Developer Platforms
This story lands in the software and developer-tools beat for one reason: the biggest check in the group funds AI infrastructure, and infrastructure is what coding tools run on. Every AI coding assistant, agent framework and model API depends on someone solving compute, orchestration and cost. When a European startup lands $100 million to work on that layer, developers should expect new options within a year or two, though nothing about Callosum’s actual release plans is confirmed.
Pricing pressure is the practical angle. Tool buyers already juggle plans that range from $20 to $500 a month, as our breakdown of Claude Code pricing against Codex and Gemini CLI shows. Cheaper or faster infrastructure from new vendors could change that math, but only if these startups actually ship products that undercut incumbents. A seed round promises capacity to try, not a result.
Editors and engineers who follow the software category can find related coverage on the software pillar page. The wider point holds regardless: developer tools are downstream of infrastructure money, and Q3 2026 showed that infrastructure money is plentiful in Europe.
Historical Context: How Seed Rounds Grew Up
The seed stage once meant a small team, a prototype and a check big enough for a year of rent and salaries. Over the past several years, AI and deep-tech companies pushed that definition outward, because training models, fabricating chips and running clinical work all demand capital before any product exists. Tech.eu’s Q3 list shows the shift in concrete form, with four of the six confirmed rounds at or above $25.5 million.
Public figures from earlier periods are not in the available extract, so this article does not quote a year-ago seed benchmark. What the data does allow is a within-quarter comparison, shown below. The spread between the top and bottom confirmed rounds is large, and the ratio between Callosum and ZuriQ is roughly 3.9 to 1 on dollar amounts alone.
| Metric | Value | Basis |
|---|---|---|
| Q3 2026 European tech funding | €27.8 billion | Tech.eu |
| Deals counted | 732 | Tech.eu |
| Growth vs Q3 2025 | 32.4% | Tech.eu |
| Average per deal (all stages) | About €38 million | Derived: €27.8B divided by 732 |
| Implied Q3 2025 total | About €21.0 billion | Derived from the 32.4% increase |
| Confirmed dollar-denominated seeds, combined | $225.5 million | Derived: $100M + $55M + $45M + $25.5M |
| Confirmed euro-denominated seeds, combined | €35 million | Derived: €20M + €15M |
| Callosum vs ZuriQ | About 3.9 to 1 | Derived: $100M divided by $25.5M |
Competitive Comparison: Where the Seed Money Went by Sector
Sorting the six confirmed rounds by sector shows how the money split. Two rounds, Callosum and microagi, target AI infrastructure. Together they account for $155 million of the $225.5 million in confirmed dollar-denominated seeds, about 69%. Aptadir’s $45 million and ZuriQ’s $25.5 million make up the remaining dollar total, while INLEAP Photonics and iPremom took the two euro rounds.
The comparison with other regions is limited by the source. Tech.eu’s extract covers Europe only, so claims that Europe leads or trails the US or China on seed size would be unsupported here. The more modest and defensible reading: within Europe, AI infrastructure drew the largest individual seed checks in the quarter among the names confirmed.
Government-backed funds are part of the picture elsewhere. The World Bank’s proposed $50M fund of funds for Pakistan shows a different model, where public money seeds a whole portfolio rather than writing single large checks. Nothing in the Tech.eu extract says public money backed any of the six rounds above, so that comparison is about structure, not about these deals.
Five Predictions for Late 2026 and 2027
These are this site’s analytical expectations, not reported facts, and none comes from Tech.eu.
- Infrastructure seeds stay large. Expect more AI infrastructure startups in Europe to announce first rounds well above what the stage meant in earlier years, as long as investor appetite for compute-adjacent plays holds.
- Robotics follows the same curve. With microagi at $55 million and neighboring pre-seeds at $30 million, robotics software companies will likely pitch for nine-figure early rounds within the next year or so.
- Hardware startups return sooner. Quantum and photonics firms like ZuriQ and INLEAP need fabrication and test capacity, so their follow-on rounds will probably arrive faster than a software company’s would.
- Regulatory news will drive iPremom’s story. Approval decisions in Europe and the US, not funding headlines, will set the pace for MaiRa after this round.
- Developer tools will borrow the infrastructure narrative. Coding-tool startups will frame their pitches around the cost and speed gains that new infrastructure vendors promise, whether or not those vendors deliver in 2027.
What Founders, Investors and Developers Should Watch Next
Founders should read the Q3 numbers as a signal about timing. A market that grew 32.4% in a year rewards well-prepared pitches, though it also raises the bar, because competitors now raise bigger rounds and hire faster. Investors should note that several of the confirmed rounds come with long, capital-heavy roadmaps, such as chip fabrication, clinical validation and robot platforms, which means returns depend on execution over years, not quarters.
Developers have a simpler checklist. Watch for product announcements from Callosum and microagi, since their stated goals involve platforms others could build on. Verify any performance claim against independent tests before adopting a new infrastructure vendor. Our earlier look at catching edit drift in Cursor’s plan mode shows the same habit applied to tooling: trust a result only after you check it.
Finally, track the unconfirmed four. When Tech.eu or the companies themselves publish details, the sector split above may shift. A single large biotech or software round among them could change the percentages in this analysis, and the article will need to reflect that.
FAQ: Europe’s Biggest Seed Rounds in Q3 2026
How much did European tech companies raise in Q3 2026? Tech.eu reported €27.8 billion across 732 deals, which is 32.4% more than in Q3 2025.
What was the largest seed round in Europe in Q3 2026? Among the six rounds confirmed in the available Tech.eu extract, Callosum’s $100 million seed for its AI infrastructure platform is the largest. Four of the ten rounds on Tech.eu’s list are not confirmed here.
Which companies raised the other confirmed seed rounds? microagi raised $55 million, Aptadir Therapeutics $45 million, ZuriQ $25.5 million, INLEAP Photonics €20 million and iPremom €15 million.
What will microagi do with its $55 million? Per Tech.eu, it plans to scale Atlas, develop AI infrastructure for industrial robots and expand its global operations. Technical details about Atlas are not confirmed.
Does iPremom’s MaiRa have regulatory approval? The funding supports clinical validation and commercial rollout, which Tech.eu says is pending further regulatory approvals in Europe and the US. No approval dates are confirmed.
Who invested in these rounds? Investor names are not confirmed in the available extract, so this article does not list any. Check the original Tech.eu report or each company’s announcement.
Why does a seed list belong in coverage of coding tools? AI coding assistants and agents depend on infrastructure, and the largest confirmed seed in the quarter funds an AI infrastructure platform. The link is indirect, and no product tie to coding tools is confirmed.
